Cerium oxide nanoparticles: A promising tool for the treatment of fibrosarcoma in-vivo

Mater Sci Eng C Mater Biol Appl. 2020 Apr:109:110533. doi: 10.1016/j.msec.2019.110533. Epub 2019 Dec 6.

Abstract

In this study, we used cerium oxide nanoparticles and evaluated their anti-cancer effects in a mouse model of fibrosarcoma. For evaluation of anti-cancer effects of nanoceria, tumor volume measurement, TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay, quantitative real-time PCR (qPCR) for Bax and Bcl2 genes, a panel of liver and kidney function tests and hematoxylin-eosin staining were done. Nanoceria dominantly accumulated in the tumor and it could significantly decrease tumor growth and volume in tumor-bearing mice that received nanoceria for four weeks. Cerium oxide nanoparticle showed potential anti-cancer properties against fibrosarcoma.

Keywords: Bax; Bcl2; Cerium oxide nanoparticles; Fibrosarcoma; TUNEL.

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cerium* / chemistry
  • Cerium* / pharmacology
  • Female
  • Fibrosarcoma / drug therapy*
  • Fibrosarcoma / metabolism
  • Fibrosarcoma / pathology
  • Mice
  • Mice, Inbred BALB C
  • Nanoparticles* / chemistry
  • Nanoparticles* / therapeutic use
  • Neoplasms, Experimental / drug therapy*
  • Neoplasms, Experimental / metabolism

Substances

  • Cerium
  • ceric oxide